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The inflammatory intestinal disorder Crohn’s disease (CD) has become a health challenge worldwide. The gut microbiota
closely interacts with the host immune system, but its functional impact in CD is unclear. Except for studies on a small
number of CD patients, analyses of the gut microbiota in CD have used 16S rDNA amplicon sequencing. Here we employed
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metagenomic shotgun sequencing to provide a detailed characterization of the compositional and functional features of
the CD microbiota, comprising also unannotated bacteria, and investigated its modulation by exclusive enteral nutrition.
Based on signature taxa, CD microbiotas clustered into 2 distinct metacommunities, indicating individual variability in CD
microbiome structure. Metacommunity-specific functional shifts in CD showed enrichment in producers of the
pro-inflammatory hexa-acylated lipopolysaccharide variant and a reduction in the potential to synthesize short-chain fatty
acids. Disruption of ecological networks was evident in CD, coupled with reduction in growth rates of many bacterial
species. Short-term exclusive enteral nutrition elicited limited impact on the overall composition of the CD microbiota,
although functional changes occurred following treatment. The microbiotas in CD patients can be stratified into 2 distinct
metacommunities, with the most severely perturbed metacommunity exhibiting functional potentials that deviate
markedly from that of the healthy individuals, with possible implication in relation to CD pathogenesis.
Keywords: Crohn’s disease; gut microbe; metagenomics; exclusive enteral nutrition
Background
Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that
may affect any part of the gastrointestinal tract. Gut microbes
have recently gained much attention as plausible drivers of CD.
This notion is supported by the fact that the intimate interac-
tion between the gut microbiota and the intestinal mucosa con-
stantly modulates and shapes the gut immune system [1], and
departure from the normal homeostatic microbiome state likely
triggers immune dysregulation via pro-inflammatory cues. Spe-
cific pathogens that possibly cause CD have been identified,
such as adherent-invasive Escherichia coli [2] and Mycobacterium
avium paratuberculosis [3]. However, these bacteria were detected
only in a fraction of patients [2, 3]. It is therefore assumed that
the overall composition of the gut microbiota rather than spe-
cific microorganisms accounts for the inflammatory state in CD.
Studies using 16S rRNA gene amplicon sequencing to character-
ize CD-associated microbiota abnormalities revealed an overall
reduced microbial diversity in CD [1, 4, 5]. Moreover, a reduc-
tion in the relative abundance of Roseburia [6], Faecalibacterium
[1, 5–7], Bifidobacteriaceae [1], and Clostridiales [5] and an increase
in the relative abundance of the Enterobacteriaceae family mem-
bers [1, 4–7] were reported in patients with CD. However, stud-
ies using 16S rRNA gene amplicon sequencing have limitations
in taxonomic resolution and functional inference. Metagenomic
shotgun sequencing can overcome these limitations, but only a
few studies have applied metagenomic shotgun sequencing on
CD microbiota, including the initial report on 4 CD cases (along
with 21 ulcerative colitis cases) to illustrate the utility of the first
gut microbial reference gene catalog [8], and a subsequent study
on 23 pediatric CD patients [9]. The current incomplete under-
standing of the functional roles played by the gutmicrobiota has
limited the efforts to devise more targeted treatments.
Conventionally, CD is treated with anti-inflammatory or im-
munosuppressive medications or by surgery if symptoms can-
not be improved pharmaceutically [10]. However, side effects
and complications such as infection and malnutrition accom-
pany these treatments [11], which imperil the patient’s life. Al-
though not widely used, exclusive enteral nutrition (EEN) is a
low-risk, noninvasive therapy for CD that involves exclusive in-
gestion of 100% liquid formula made up of either elemental or
polymeric nutrients [12]. In pediatric CD, up to 85% remission
has been achieved by EEN [12]. Nevertheless, in adult CD, EEN
has not delivered desirable effectiveness, which to some extent
may be attributed to nonadherence and interpersonal variations
in clinical conditions [12]. Themechanism underlying the allevi-
ation of CD by EEN also remains unclear, though nutritional im-
provement and microbial involvement possibly play a role [13].
Although previous studies have described the effects of EEN on
themicrobiota of pediatric CD [9, 14], it is unclear how EENmod-
ulates the adult counterpart.
Through metagenomic sequencing and data analysis, we
herein provide novel insights into the CD microbiota at both
compositional and inferred functional levels. We identified 2
metacommunity stages within CD patients that differed by
the abundance of gram-negative pro-inflammatory bacteria
and presence of genes involved in the production of anti-
inflammatory short-chain fatty acids. In addition, we investi-
gated the effect of short-term EEN on the CD microbiota. Our
study highlights the presence of 2 microbiota severity states re-
lated to gut microbiota dysbiosis in CD and indicates possible
functional links between the microbiota and the underlying im-
munological dysbalance in CD.
Data Description
Forty-nine CD patients and 54 healthy controls (CTs) were en-
rolled in this study. Fourteen CD patients underwent EEN treat-
ment (for the clinical profiles of CD patients, see Supplemen-
tary Table S1). Fecal samples were collected from all participants
at baseline and from the EEN-treated patients after 2-week EEN
treatment, totaling 117 fecal samples. After DNA extraction, a
DNA library of an insert size of 350 bp was constructed and then
sequenced on an IlluminaHiSeq 2000 analyzer at BGI (Shenzhen,
China) using 100 bp paired-end (PE) sequencing. In total, we gen-
erated ∼700 Gb raw data, and 672 Gb of the data remained after
filtering out low-quality or host reads. The dataset is available
from the EBI Database (Accession No. PRJEB15371) [15]. On av-
erage ∼55.65 million high-quality reads per sample were gener-
ated for further analyses. The proportion of high-quality reads
among all raw reads from each sample was 95.98% on average.
Using both de novo assembly and alignment against the inte-
grated gene catalog geneset, 2 036 584 genes with an occurrence
rate over 5% were obtained.
Analyses
Clustering of CD microbiota into distinct
metacommunities
When the gutmicrobiotas of CD patients were compared to their
non-CD counterparts, both microbial gene counts (Supplemen-
tary Fig. S1a) and diversity (Supplementary Fig. S1b) were con-
siderably lower in CD patients than in CTs. For high-confidence
taxonomic identification, co-abundant genes were binned into
metagenomics species (MGS; harboring more than 700 genes)
[16], which were thereafter used for taxonomic annotation. A to-
tal of 452 MGS were identified, with 151 of them being assigned
to existing taxonomic entities (Supplementary Table S2).
To capture the principal differences between non-CD and
CDmicrobiome structures, we adopted a combinatory approach
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Figure 1: Clustering of gut microbiota into metacommunities associated with CD. (a) Heatmap of signature microbes for 3 metacommunities determined by the DMM
model. Rows correspond to 85 discriminative MGS, with hierarchical clustering by their relative abundances. Taxonomic annotations of these MGS are indicated at
the right and colored by phylum. Each column corresponds to 1 sample. The disease status (the first horizontal bar) and metacommunity membership (the second
horizontal bar) of samples are indicated by color at the top, and MD index for each sample is represented by gray scale (the third horizontal bar). (b) PCoA of the 85
MGS based on Jensen-Shannon distance (JSD). Colors indicate metacommunity memberships, and shapes (triangle or round) denote disease states (CT or CD).
that started with sample clustering based on the dirichlet multi-
nomial mixtures (DMM) model [17], followed by the identifica-
tion of discriminative microbes using an adapted version of the
linear discriminant analysis (LDA) effect size (LEfSe)method [18].
Based on Laplace approximation [17], we identified 3 clusters
as exhibiting minimal negative log posterior (Supplementary
Fig. S1c). Based on this, we clustered the microbiome samples
of CD and CTs into 3 metacommunities (A, B, and C), which dis-
played intracommunity homogeneity and intercommunity dis-
similarity (Fig. 1a). The membership of a metacommunity was
associated with disease status (Fisher’s exact test with BH ad-
justment, q < 0.01) (Supplementary Table S3). Metacommunity
A was dominated by CT samples, and metacommunity C ex-
clusively by CD samples, whereas metacommunity B contained
both CT and CD samples (Fig. 1a). Based on a less stringent LEfSe
method, 85 MGS were identified as discriminative microbes for
the metacommunities or subgroups (CT and CD groups within
metacommunity B) (Fig. 1a and Supplementary Table S4). The
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majority of metacommunity A–enriched MGS were reduced in
metacommunity B and further depleted in C, including short-
chain fatty acid (SCFA)–producing bacteria such as Bifidobac-
terium species, Faecalibacterium prausnitzii, Alistipes shahii, and
Roseburia species (Fig. 1a and Supplementary Table S4). Among
others, SCFA-producing bacteria Bacteroides cellulosilyticus, Bac-
teroides xylanisolvens, and Clostridium nexile, a member of the im-
munomodulatory Clostridium cluster XIVa [19], were enriched
in metacommunity B (Fig. 1a and Supplementary Table S4). An-
other Clostridium cluster XIVa clade member, Clostridium sym-
biosum, and a number of opportunistic pathogens such as E.
coli, Klebsiella pneumoniae, Streptococcus salivarius, and Clostridium
bolteae were overrepresented in metacommunity C (Fig. 1a and
Supplementary Table S4), suggesting that subjects in this group
had impaired ability to suppress colonization by pathogenic
species in their gut. We also evaluated whether metacommu-
nities differed in the degree of dysbiosis associated with CD
through computing themicrobial dysbiosis index (MD-index) [5].
CDmicrobiotas frommetacommunity C had significantly higher
values on the MD-index than those from metacommunity B
(P = 7.63e-05) (Fig. 1a and Supplementary Table S1), suggesting
a more severe degree of dysbiosis in this CD subgroup. Com-
bined, these compositionally distinctmetacommunities recapit-
ulate disparate configurations of the microbiota under normal
and CD conditions.
The separation of microbiomes into metacommunities was
confirmed by principal coordinate analysis (PCoA), which clus-
tered samples by both metacommunity identity and disease
status (Fig. 1b). We determined whether the variations in mi-
crobiome composition were accompanied with clinical pheno-
types. In CD patients, 23 clinical variables together with age
correlated with microbiome variation, with uric acid and blood
leukocyte numbers being the top 2 covariates (effect size > 0.2)
(Supplementary Fig. S2b). When categorized into groups, vari-
ous plasma biomarkers, including inflammatory markers, were
the strongest classes of covariates (effect size> 0.2) (Supplemen-
tary Fig. S2c). However, despite the existence ofmicrobiome vari-
ations and their correlation with clinical states, no significant
differences were detected for these clinical variables between
metacommunity B and C CD patients (Supplementary Fig. S2d).
CD- and metacommunity-associated functional traits
We next analyzed the functional changes associated with dis-
ease status and differences in microbiome structure. We made
pair-wise comparisons after performing functional annotation
using the Kyoto Encyclopedia of Genes and Genomes (KEGG)
database (KEGG, RRID:SCR 012773). A large number of CD- and
metacommunity-related functional shifts were identified at the
level of pathways and modules (Fig. 2a, Supplementary Table S5
and Supplementary Table S6). We observed consistent changes
in CD microbiotas in all within- or between-metacommunity
comparisons (in B-CD vs A-CT, C-CD vs A-CT, B-CD vs B-CT, and
C-CD vs B-CT) (Fig. 2a). The composition of the microbiota of CD
patients indicated consistent changes in the potential for carbo-
hydrate utilization compared to the CT counterparts with a de-
creased abundance of pathways involved in starch and sucrose
metabolism, and enrichment of pathways involved in simple
carbon metabolism such as fructose, mannose, and galactose in
themicrobiotas of CD patients (Fig. 2a). In addition, we observed
an enrichment of genes in pathways involved in glyoxylate, di-
carboxylate, propanoate, and butanoate metabolism, as well as
in pathways involved in transport of simple sugars (phospho-
transferase system) (Fig. 2a). Interestingly, the reporter scores of
numerous amino acidmetabolic pathways exhibitedmarked de-
creases or increases in CD patients compared to CTs, suggesting
possible significant changes in the amino acidmetabolic profiles
(Fig. 2a). Of note, the potential for methanemetabolismwas also
diminished in CD patients (Fig. 2a). By contrast, microbes in CD
patients exhibited enhanced potential for xenobiotic degrada-
tion (e.g., of toluene, fluorobenzoate, styrene, benzoate, dioxin,
and xylene) and antioxidant defense (e.g., ascorbate, aldarate,
and glutathione metabolism) (Fig. 2a). In parallel, a number of
pathways associated with pathogenesis and virulence, includ-
ing ABC transporters, bacterial secretion system, and general
lipopolysaccharide (LPS) biosynthesis, exhibited an incremental
enrichment from metacommunity A to C (Fig. 2a).
LPS, an inherent component of Gram-negative bacteria, is
an endotoxin that can have opposing effects on the immune
response [20]. Since pathway and module analyses showed
an enrichment of general LPS biosynthesis in the CD micro-
biome (Fig. 2a), we took a novel approach and investigated
the capacity among all Gram-negative bacteria to produce
the pro-inflammatory hexa-acylated LPS, as compared to the
antagonizing silencing penta-acylated LPS variant [21, 22]. We
listed bacteria with a potential for synthesizing each LPS vari-
ant (Supplementary Table S7) and compared the abundances
of these bacteria (Supplementary Table S8). The hexa-acylated
LPS-producing bacteria E. coli and Morganella morganii exhibited
higher abundance in CD patients from metacommunity C com-
pared to non-CD individuals from metacommunity A (Supple-
mentary Table S7). Consistently, compared to metacommunity
A (CT), microbes in metacommunity C (CD) tended to produce
LPS in a higher hexa- to penta-ratio, suggested by the increase in
abundance of bacteria with the hexa- over the penta-acetylated
LPS variant (Fig. 2b), which in part may account for an increased
inflammatory stimulation of the CD gut.
The abundances of Gram-positive bacteria were reduced in
metacommunity C, and in metacommunity B as compared to
CTs (Fig. 2b). These bacteria make up the largest reservoir for
production of SCFAs. SCFAs are not only colonotrophic nutri-
ents but also immunoregulatory molecules [23] that may reduce
pro-inflammatory cues within the gut environment. We esti-
mated the abilities of the metacommunities to produce the SC-
FAs acetic acid, propionic acid, and butyric acid. This was done
based on the presence of the genes encoding the last enzyme
within the respective biosynthetic pathway, thereby providing
an alternative method for predicting the capacity for biosynthe-
sis of the bioactive end products than that used in Fig. 2a, which
was based on presence of genes involved in overall metabolic
pathways. Bacteria with a potential to produce SCFAs are listed
in Supplementary Table S7. Evidently, CD microbiotas, partic-
ularly those in metacommunity C, showed a decreased abun-
dance of key genes for SCFA production, including acetic acid,
propionic acid, and butyric acid, when compared to the CT mi-
crobiota in metacommunity A (Fig. 2c). Concordantly, the abun-
dance of many SCFA-producing bacteria differed between CT
and CD samples (Supplementary Table S8). Thus, the gut mi-
crobiota in CD patients likely produces a suboptimal amount of
SCFAs compared to the healthy state.
Disruption of the normal gut microbial ecosystem and
bacterial growth rate in CD
The structure of a microbiota is the result of dynamic interac-
tions between community members. We generated correlation-
based microbial interaction networks using the SparCC
algorithm (Fig. 3 and Supplementary Fig. S3). Since
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Figure 2: Functional alterations of the gut microbiota in CD. (a) Heatmap and hierarchical clustering of KEGG pathways that are differentially enriched between
the microbiota groups identified in Fig. 1a. Color scale represents reporter score, and only KEGG pathways with a reporter score greater than 1.9 are shown. (b)
Relative abundances of Gram-negative MGS (the first left panel), Gram-positive MGS (the second left panel), penta-acylated LPS-producing MGS (the middle panel),
hexa-acylated LPS-producing MGS (the second last panel), and the ratio of hexa- to penta-acylated LPS-producing MGS (the last panel) across different groups. The
value of relative abundance was log-transformed. (c) Relative abundances of genes encoding key enzymes for the biosynthesis of different SCFAs across different
microbiota groups. Carbonmonoxide dehydrogenase and acetyl coenzyme A (CoA) synthase complex are crucial for acetic acid production; propionyl-CoA transferase
and propionyl-CoA/succinyl-CoA transferase are responsible for propionate acid synthesis; butyryl CoA transferase accounts for butyric acid generation. Their relative
abundances were log-transformed. (b, c) Statistical comparison by Wilcoxon test followed by a Benjamini-Hochberg correction for significance level; ∗q < 0.2; ∗∗q < 0.1;
∗∗∗q < 0.05; ∗∗∗∗q < 0.001.
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Figure 3: Reconstruction of microbial interaction networks by CD. Co-occurrence (blue) relationships and co-exclusion (red) between taxa were estimated by SparCC
algorithm, and correlation networks were compared between non-CD samples from metacommunity A (a, A-CT) and CD samples from metacommunity C (b, C-CD).
Only relationships with coefficients above 0.3 are visualized, and the thickness of lines denotes the strength of the correlation, as indicated in the legend. Node size
represents mean taxon abundance in networks, and node color represents the growth rate of each species (gray indicates no detection). Taxa of the same bacterial
phylum are encircled by dashed lines.
metacommunities A and C were representative of the typ-
ical CT and CD states, respectively, we first compared the
microbiome networks of these 2 groups (Fig. 3a and b). The
control microbiota in metacommunity A was characterized
by a complex network of interactions between different taxa,
especially within or between the dominant phyla Bacteroidetes
and Firmicutes (Fig. 3a). However, the vast majority of these
relationships were no longer significant in the CD patients
harboring metacommunity C (Fig. 3b). Among the strong
interactions lost in the gut microbiota of the C-CD group
were positive correlations (r > 0.5) of Bacteroides cellulosilyticus
with Bacteroides thetaiotaomicron and Bacteroides sp., and of
Ruminococcus bromii with Eubacterium ventriosum (Fig. 3). Only
1 new strong correlation was formed between 2 unidentified
taxa in the C-CD group (Fig. 3). Thus, the CD microbiota of
metacommunity C showed not only alterations in composition,
but also reduced interrelationships. In comparison, CT and CD
microbiotas from metacommunity B did not differ significantly
in terms of network complexity, although numerous intertaxon
relationships were altered (Supplementary Fig. S3).
Changes in bacterial growth rate may contribute to alter-
ations in community structures. We calculated the growth rate
from the number of sequencing reads covering the replication
origin relative to reads covering the replication termination site
[24]. Compared to CTs in metacommunity A, the growth rate of
many beneficial taxa decreased in metacommunity C, including
the SCFA-producing bacteria Alistipes finegoldii, Alistipes shahii,
Eubacterium rectale, Roseburia intestinalis, and several Faecalibac-
terium prausnitzii strains (Fig. 3 and Supplementary Table S9).
Interestingly, certain pathogenic or opportunistic pathogenic
bacteria exhibiting an increased abundance in the C-CD group
showed high growth rates (E. coli, Klebsiella pneumoniae, Bac-
teroides fragilis, and Streptococcus salivarius) (Fig. 3, Supplemen-
tary Fig. S4, and Supplementary Table S9). Thus, differences in
growth rate likely contribute to the alterations in the relative
abundance of bacteria in CTs and CD patients since the observed
increase or decrease in growth rates largely concurredwith their
changes in relative abundance in CD samples (Supplementary
Fig. S4). The reduction of growth rates for most bacteria in the
C-CD group may also be an indicator that this metacommunity
structure is unlikely to shift toward increased diversity over time
without specific intervention.
Limited remodeling of CD microbiota composition by
short-term EEN
Fourteen patients in our cohort underwent EEN treatment after
baseline sampling and provided fecal samples after 2 weeks of
treatment. We assessed whether short-term EEN was sufficient
to alter the microbiome structure in CD patients. For all patients
but 1 (GZCD029,marked by ∗ in Fig. 4b), such short time interven-
tion proved insufficient to change their metacommunity identi-
ties (Fig. 4a), in accord with no significant change in MD-indices
(P = 0.20) (Fig. 4a and Supplementary Table S1). However, mod-
erate changes occurred, as illustrated by the shift in the relative
position ofmicrobiomes along the 2 principal coordinateswithin
pre-identified clusters (Fig. 4b).
Despite the limited remodeling of the overall micro-
biota composition, 2 weeks of EEN did induce a variety of
functional alterations (Fig. 4c, Supplementary Table S12, and
Supplementary Table S13). In a reversemanner to CD-associated
shifts, functions such as LPS biosynthesis and the bacterial
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Figure 4: Moderate modification of CD microbiota by EEN treatment. (a) Gut MGS from CD patients (n = 14) before and after 14 days of EEN were clustered into
metacommunities and visualized as a heatmap representing the 85 discriminative MGS (as in Fig. 1a). Each column corresponds to 1 sample. (b) PCoA of pre- and post-
EEN CDmicrobiota based on Jensen-Shannon distance (JSD). Arrows indicate the shift of position along the first 2 principal coordinates pre- to post-EEN treatment. The
sample whose metacommunity identity changed after EEN treatment is marked with an asterisk (GZCD029). (c) Heatmap and hierarchical clustering KEGG pathways
that were enriched or decreased in post- vs pre-EEN. Color scale represents reporter score, and only KEGG pathways with a reporter score greater than 1.9 are shown.
(d) Log10 relative abundances of Gram-negative MGS (the first left panel), Gram-positive MGS (the second left panel), penta-acylated LPS-producing MGS (the middle
panel), hexa-acylated LPS-producing MGS (the second last panel), and the ratio of hexa- to penta-acylated LPS-producing MGS (the last panel) in pre- vs post-EEN.
(e) Log10 relative abundances of genes encoding key enzymes for the biosynthesis of different SCFAs in pre- vs post-EEN, as calculated in Fig. 2c. (d, e) Statistical
comparison by Wilcoxon test, followed by a Benjamini-Hochberg correction for significance level, showed no changes between groups.
secretion system became less enriched, while starch and su-
crose metabolism and flagellar assembly were enhanced after
EEN (Fig. 4c), suggesting a partial functional recovery. However,
certain CD-driven changes, such as functions associated with
ribosomes, 1 carbon folate pool, phosphotransferase system,
and ABC transporters, were exacerbated after 2 weeks of EEN
(Fig. 4c), indicating either side effects or temporal disease pro-
gression. Nevertheless, short-term EEN did not affect the abun-
dances of LPS- or SCFA-producing bacteria (Fig. 4d and e and
Supplementary Table S10) or their growth rates (Supplemen-
tary Table S11). However, network rewiring occurred (Supple-
mentary Fig. S5). Rather than interacting with Firmicutes, bac-
teria from Bacteroidetes tended to interact with each other after
EEN treatment (Supplementary Fig. S5). By contrast, a majority
of Firmicutes in patients after EEN treatment presented more
interdependences with Proteobacteria and unclassified species
compared to those before treatment (Supplementary Fig. S5).
Overall, the CDmicrobiota appeared relatively stable and refrac-
tory to 2-week EEN intervention. Future studies will need to de-
termine if a longer intervention period with EEN will result in
restoration of normal functional microbiota in CD patients.
Discussion
Comparative metagenomic analysis of fecal samples from CD
patients and heathy controls revealed pronounced global alter-
ations in the fecal microbiota of CD patients, characterized by 2
distinct CDmetacommunities comprising gradually limited bac-
terial diversity, by functional aberrations toward a pronounced
pro-inflammatory phenotype, and by structural derangements
of ecosystem networks.
Metacommunities constitute a robust means to distin-
guish microbiotas with different traits and of distinct natures.
Suggested by their signature microbes (the leverage between
beneficial bacteria or opportunistic pathogens) and supported
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by the MD-index, metacommunity A might be representa-
tive of the healthy gut, while metacommunities B and C
likely represented a moderately imbalanced and a more pro-
inflammatory state associated with CD, respectively. Since
the commensal microbiota is closely linked to the health of
the host, the classification of metacommunities is a novel
promising tool to stratify patients based on their microbiome
configuration.
Our study identified systematic functional alterations of the
CD microbiome that reflected the stressful microenvironment
of the CD gut and its predisposition to inflammation. In this re-
spect, the decline in the potential for the biosynthesis of all SC-
FAs, which may modulate the activation of the immune system
and temper inflammation [25, 26], and the appearance of mi-
crobes producing the pro-inflammatory hexa-acetylated LPS [20]
are salient manifestations of the inflammation-prone nature of
the CD microbiota. Although LPS has long been established as
a pathogen-associated molecular pattern that triggers immune
cascades [20], it was more recently established that only the
hexa-acylated LPS variant is able to activate pro-inflammatory
cues via TLR4 in humans [22], while the penta-acylated LPS vari-
ant acts as an antagonist [21]. Our finding that the CD micro-
biota of metacommunity C was enriched in microbes producing
hexa-acylated LPS is consistent with previous observations of
the increased abundance of the Enterobacteriaceae family mem-
bers in CD [1, 4–7], which are known to stimulate inflammation
[27]. Together, these changes may severely affect the host im-
mune system, leading to an unchecked inflammatory state in
CD. The reduction in the network complexity of the CD micro-
biota of metacommunity C reinforced the view that a globally
disturbed microbial ecosystem may contribute to this disease.
The loss of reciprocal and cross-inhibitory relationshipsmay im-
pair the survival of beneficial microbes and create favorable con-
ditions for the blooming of pathogens. Likewise, it appears to
limit the growth of many gut bacteria found in healthy individ-
uals. In this regard, reconstruction of the normal ecosystem and
not only the mere introduction of a single or several commen-
sal microbes may be needed to curb CD. In the case of EEN, a
longer term of treatment may be needed to achieve this goal.
Analysis of the fecal microbiota is widely used as a proxy for
studying the gutmicrobiota composition because of the easiness
and noninvasive nature of fecal sampling, and it has through the
years resulted in deepening the understanding of the relation-
ship between the gut microbiota and IBD [1, 28]. However, new
avenues of sampling procedures provide more comprehensive
insights into the role played by the intestinal location of micro-
bial species (luminal or mucosal layer attachment to the small
and the large intestine) that, in combination with metagenomic
sequencing, would allow for deeper insights into the interindi-
vidual diversity in ecological dysbalance in CD patients in future
studies.
Taken together, our metagenome-scale characterization of
the CD gut microbiome supports the notion of a shift toward en-
hanced pro-inflammatory capacity, which is most pronounced
in individuals harboring the severe-state metacommunity C.
The level of details in this analysis, also encompassing yet-
unannotated bacteria, may pave the way for elucidating mi-
crobial disturbances predictive for CD by enabling the discov-
ery of composite microbial CD biomarkers. In addition, it may
allow for the identification of future therapeutic targets based
on microbiota signatures, thereby implementing personalized
medicine to CD patients based on the individual microbiome
composition.
Methods
Study cohort, EEN treatment, and sample collection
Forty-nine CD patients and 54 healthy controls were enrolled in
this study at the Sixth Affiliated Hospital of the Sun Yat-sen Uni-
versity, Guangdong, China. All patients met the diagnostic crite-
ria for CD, according to the Montreal classification system [29].
Patients diagnosed with diabetes or tumor, cardiovascular, kid-
ney, liver, andmetabolic diseases were excluded from this study.
Among these participants, 14 CD patients underwent EEN
treatment. ENSURE R© (Abbott Laboratories, Abbott Park, IL,
USA), PEPTISON R©, NUTRISON POWDER R© (NUTRICIA, Danone,
Netherlands), and FRESUBIN R© (Sino-Swed Pharmaceutical
Corp. Ltd, China) were used as the standard oral polymeric
formulas, and their ingredients are detailed in Supplementary
Table S14. Patients chose from these formulas, with 8 patients
selecting ENSURE R© and the others selecting a mixture of 2 or
more formulas. Formulas were consumed at 30 kcal/kg per day
as the sole nutrient source. Patients who adhered to EEN treat-
ment had their lesion healed.
Fecal sampleswere collected from all participants at baseline
(n = 103) and from the EEN-treated CD patients after 2 weeks of
treatment (n = 14), totaling 117 samples. The fecal samples were
immediately frozen and stored at –80◦C until being processed.
DNA extraction was performed according to the protocols de-
scribed previously [30].
Metagenomic sequencing and assembly
Paired-end metagenomic sequencing was conducted on the
Illumina platform (insert size, 350 bp; read length, 100 bp).
Quality control was performed, and adaptor and host con-
tamination were filtered. Sequencing reads were de novo as-
sembled into contigs with SOAPdenovo v. 2.04 (SOAPdenovo2,
RRID:SCR 014986) [31], as described previously [30].
Co-abundance gene group identification and functional
annotation
Applying the metagenomic species (MGS) clustering method
[16], we clustered genes according to their covariations in abun-
dance across samples. A group of co-abundant genes was iden-
tified as an MGS if it contained 700 or more genes. These MGS
were subjected to subsequent analysis. Taxonomic assignment
of the mapped genes was performed according to the Integrated
Microbial Genomes (v. 400) database using an in-house pipeline
detailed previously [30], with 70% overlap and 65% identity for
assignment to phylum, 85% identity to genus, and 95% iden-
tity to species. The relative abundance of a co-abundance gene
group was calculated from the relative abundance of its genes.
Differentially enriched KO pathways or modules were iden-
tified according to their reporter scores [32], which were calcu-
lated from the Z-scores of individual KOs.
We assessed the production capacity for the 2 LPS forms
based on the abundances of genes of the entire lipid A biosyn-
thesis pathway, and separated them into penta-acylated LPS
producers (harboring all lipid A pathway genes except for LpxM)
and pro-inflammatory hexa-acylated LPS producers (all lipid A
pathway genes). MGS with no lipid A pathway genes were as-
signed as Gram-positive bacteria.
Sequences of SCFA-producing enzymes were retrieved as
previously described [33]. Genes in the reference gutmicrobiome
gene catalog [8] were identified as these enzymes (best match
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Table 1: Summary metadata of all participants
Patient characteristics Control CD Permanova P-value
Number of samples 54 49 –
Age, mean ± SD, y 20.70 ± 7.76 28.82 ± 8.04 0.01
Gender, No. (%) 0.02
Male 51 (94.44) 36 (73.47)
Female 3 (5.56) 13 (26.53)
BMI, mean ± SD, kg/m2 21.49 ± 3.28 18.91 ± 2.85 0.001
Lesion location, No. (%)
UGIT – 3 (6.12) –
Jejunum – 3 (6.12) –
Ileum – 40 (81.63) –
Cecum – 5 (10.20) –
Colon – 35 (71.43) –
Nutritional status, No. (%)
Dystrophy-severe – 5 (10.20) –
Dystrophy-medium – 7 (12.29) –
Dystrophy-mild – 9 (18.37) –
Good – 15 (30.61) –
Fine – 10 (20.41) –
EEN treatment, No. (%) – 14 (28.57) –
14 resampled after EEN treatment
according to BlastP [BLASTP, RRID:SCR 001010], identity > 35%,
score > 60, E < 1e-3), and their relative abundances could then
be determined accordingly.
α-Diversity and gene count
α-Diversity (within-sample diversity) was calculated on the ba-
sis of the gene profile of each sample according to the Shannon
index, as described previously [30]. The total gene count in each
fecal sample was determined as in Le Chatelier et al. [34]. Genes
with at least 1 mapped read were considered present.
PERMANOVA of the influence of clinical and lifestyle
factors
Permutational multivariate analysis of variance (PERMANOVA)
[30] was performed on the gene abundance profiles of the
samples to assess the effects of each of the factors listed in
Table 1. We used Bray-Curtis distance and 9999 permutations
in R (3.10, vegan package, R Project for Statistical Computing,
RRID:SCR 001905) [35].
Details of updated LEfSe algorithm
Differential abundance analyses were performed using a less
stringent LEfSe algorithm to identify feature microbes whose
abundances differed at least in 1 comparison [5]. Metacommu-
nities and subgroups in metacommunity B were included for
comparisons. The biomarker relevance was ranked according to
bootstrapped (n = 30) logarithmic linear discriminant analysis
scores of at least 2. The open source R code is available at [36].
Effect size analysis
Twenty-four metadata covariates and their combined effect size
when pooled into the broader predefined categories (blood fat,
coagulation, inflammation markers, and plasma biomarkers)
were estimated with the bioenv function in the vegan R package,
which selects the combination of covariates with the strongest
correlation tomicrobiota variation (Pearson correlation between
Gower distances of covariates and microbiome Bray-Curtis dis-
similarity) (Supplementary Fig. S2A).
Correlation network inferred by phylogenetic marker
genes
Eighty-five MGS, which were previously selected via the de-
tection of microbial community clusters through DMM mod-
eling, were subjected to compositionality data analysis using
the SparCC algorithm [37]. Taxon–taxon correlation coefficients
were estimated as the average of 20 inference iterations with a
strength threshold of 0.25. Correlations with corresponding em-
pirical P-values of less than 0.01 were retained, which was cal-
culated via a total of 10 000 simulated data sets. This set of it-
erative procedures was applied separately to data from CTs and
CD patients, and to patients’ data before and after EEN to infer
the correlation values. Correlation coefficients with magnitude
of 0.3 or greater were selected for visualization in Cytoscape (v.
3.3.0, Cytoscape, RRID:SCR 003032).
Additional files
Supplementary Table S1: Clinical characteristics of participants
and the dysbiosis index for their gut micorbiome.
Supplementary Table S2:MGS of the IBD cohort. Clusters con-
taining >700 genes were annotated according to available bac-
teria and archaea genomes, as was described previously [30].
Supplementary Table S3: Association between metacommu-
nity and CD status. P-values from Fisher’s exact tests were ad-
justed by Benjamini-Hochberg step-up procedure.
Supplementary Table S4: Results of differential abundance
analysis on signature MGS for metacommunities. An adapted
version of the LDA effect size method was applied for selecting
differential MGS. Thosewith an LDA score over 2were visualized
in Fig. 1 and Supplementary Table S4.
Supplementary Table S5: Summary of differential abundance
analysis on KEGG pathways between subgroups. Differentially
enriched KO pathways were identified according to their re-
porter scores.
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Supplementary Table S6: Summary of differential abundance
analysis on KEGG modules between subgroups. Differentially
enriched KO pathways were identified according to their re-
porter scores.
Supplementary Table S7: A list of LPS/SCFA-producing bacte-
ria that had differential abundance/growth rate between sub-
groups (q < 0.2). Statistical comparison by Wilcoxon test fol-
lowed by a Benjamini-Hochberg correction for significance level.
Supplementary Table S8: Results of Wilcoxon test on the rel-
ative abundance of all MGS between subgroups. A Benjamini-
Hochberg correction was applied for significance level.
Supplementary Table S9: Results of Wilcoxon test on the
growth rate of all MGS between subgroups. A Benjamini-
Hochberg correction was applied for significance level.
Supplementary Table S10: Results of Wilcoxon test on the
relative abundance of all MGS in pre- vs post-EEN CD samples.
A Benjamini-Hochberg correction was applied for significance
level.
Supplementary Table S11: Results of Wilcoxon test on the
growth rate of all MGS in pre- vs post-EEN CD samples. A
Benjamini-Hochberg correction was applied for significance
level.
Supplementary Table S12: Summary of differential abun-
dance analyses on KEGG pathways in pre-EEN and post-EEN CD
samples. Differentially enriched KO pathways were identified
according to their reporter scores.
Supplementary Table S13: Summary of differential abun-
dance analyses on KEGG modules in pre-EEN and post-EEN CD
samples. Differentially enriched KOmodules were identified ac-
cording to their reporter scores.
Supplementary Table S14: Detailed formula of the 4 nutrition
powders applied in this study.
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